T 0715/10 (Stable liquid exendin formulations/Amylin Pharmaceuticals) of 16.09.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T071510.20140916
- Date of decision
- 16 September 2014
- Case number
- T 0715/10
- Petition for review of
- -
- Application number
- 00914425.4
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Novel exendin agonist formulations and methods of administration thereof
- Applicant name
- Amylin Pharmaceuticals, Inc.
- Opponent name
- Sanofi-Aventis Deutschland GmbH
Zealand Pharma A/S - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114(2)European Patent Convention Art 123(2)European Patent Convention Art 123(3)Rules of procedure of the Boards of Appeal Art 12(1)Rules of procedure of the Boards of Appeal Art 12(3)
- Keywords
- Amendments - extension beyond the content of the application as filed (no)
Amendments - extension of protection (no) - Catchword
- -
- Cited cases
- T 1721/07
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance for further prosecution on the basis of the appellant's first auxiliary request as filed with its letter dated 21 August 2014.